Group One Trading’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.32M Buy
+45,393
New +$9M 0.01% 985
2026
Q1
– Sell
-40,145
Closed -$4.05M – 8587
2025
Q4
$3.2M Buy
40,145
+35,865
+838% +$2.35M 0.01% 1857
2025
Q3
$200K Buy
+4,280
New +$168K ﹤0.01% 4666
2025
Q1
– Sell
-3,201
Closed -$130K – 8275
2024
Q4
$140K Sell
3,201
-2,347
-42% -$118K ﹤0.01% 4233
2024
Q3
$252K Sell
5,548
-293
-5% -$12.8K ﹤0.01% 3418
2024
Q2
$227K Buy
+5,841
New +$218K ﹤0.01% 3286
2024
Q1
– Sell
-3,088
Closed -$91.5K – 7844
2023
Q4
$88.6K Buy
+3,088
New +$74.2K ﹤0.01% 4568
2023
Q2
– Sell
-238
Closed -$5.84K – 8135
2023
Q1
$5.16K Buy
+238
New +$5.86K ﹤0.01% 6265
2022
Q4
– Sell
-21,000
Closed -$414K – 7981
2022
Q3
$414K Buy
21,000
+200
+1% +$4.4K ﹤0.01% 3415
2022
Q2
$405K Buy
+20,800
New +$405K ﹤0.01% 3627

Other funds holding RVMD

Group One Trading's RVMD Position: Q3 2026 in Review

Group One Trading opened a new position in Revolution Medicines (RVMD) in Q3 2026: 45,393 shares worth $9.32M. The stake represents 0.01% of the portfolio and ranks #985 among its holdings. This is a return to the name: Group One Trading previously reported a position in RVMD as recently as Q4 2025.

Group One Trading first reported a position in RVMD in Q2 2022 and has held it in 10 quarters since. 757 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Group One Trading held 45,393 shares of Revolution Medicines worth $9.32M as of Q3 2026.
  • Revolution Medicines was a new Group One Trading position in Q3 2026.
  • Revolution Medicines made up 0.01% of Group One Trading's portfolio in Q3 2026, its #985 holding.
  • Group One Trading first reported a position in Revolution Medicines in Q2 2022 and has held it in 10 quarters since.
  • 757 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.